terfenadine has been researched along with Alopecia Circumscripta in 4 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the effect of fexofenadine on extensive alopecia areata (AA), we evaluated retrospectively 121 patients with AA having alopecia in more than 50% of the scalp and followed them for at least 6 months." | 7.75 | Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. ( Inui, S; Itami, S; Nakajima, T; Toda, N, 2009) |
| " In this study, we investigated the anti-pruritic effect of the antihistamine, fexofenadine, on the itch of contact dermatitis that was induced by topical application of diphenylcyclopropenone for the treatment for alopecia areata." | 7.73 | Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. ( Arakawa, S; Fujiwara, S; Hatano, Y; Katagiri, K, 2006) |
| "To study the effect of fexofenadine on extensive alopecia areata (AA), we evaluated retrospectively 121 patients with AA having alopecia in more than 50% of the scalp and followed them for at least 6 months." | 3.75 | Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. ( Inui, S; Itami, S; Nakajima, T; Toda, N, 2009) |
| " In this study, we investigated the anti-pruritic effect of the antihistamine, fexofenadine, on the itch of contact dermatitis that was induced by topical application of diphenylcyclopropenone for the treatment for alopecia areata." | 3.73 | Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. ( Arakawa, S; Fujiwara, S; Hatano, Y; Katagiri, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inui, S | 2 |
| Nakajima, T | 2 |
| Toda, N | 1 |
| Itami, S | 2 |
| Nonomura, Y | 1 |
| Otsuka, A | 1 |
| Miyachi, Y | 1 |
| Kabashima, K | 1 |
| Katagiri, K | 1 |
| Arakawa, S | 1 |
| Hatano, Y | 1 |
| Fujiwara, S | 1 |
4 other studies available for terfenadine and Alopecia Circumscripta
| Article | Year |
|---|---|
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobuta | 2009 |
Case of intractable ophiasis type of alopecia areata presumably improved by fexofenadine.
Topics: Adult; Alopecia Areata; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Terfenadine; Young A | 2012 |
Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Cohort Studies; Cyclopropanes; Dermatitis, Contact; Dose-R | 2006 |
Two cases of alopecia areata responsive to fexofenadine.
Topics: Adult; Aged; Alopecia Areata; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Terfenadine | 2007 |